Best Supplements to Take With NMN

Why NMN Needs More Than a Glass of Water to Work

NMN is not a drug that binds a receptor and fires a signal. It is raw material. The full name is nicotinamide mononucleotide, and what it does is give your cells a shortcut to making NAD+, the molecule every cell in your body runs on. NAD+ is what lets your mitochondria generate energy, what your DNA repair enzymes consume when they fix damage, and what the sirtuin proteins that regulate cellular aging use as their fuel. The problem is that NAD+ levels decline with age, and the body's usual routes to replenishing it become less efficient over time. NMN sidesteps the slowest of those routes and delivers a direct precursor.

That is the part most people understand when they start taking it. Here is the part most people do not: the enzyme that converts NMN into NAD+ is called NMNAT, and it operates in three forms across different compartments of the cell, including inside the mitochondria. All three require magnesium as a cofactor. If your magnesium status is marginal, the conversion step runs at a fraction of its capacity before NAD+ is even made. You are paying for the raw material while the production line is undersupplied.

Once NAD+ is made, a second problem emerges. When the sirtuins and DNA repair enzymes that NAD+ powers do their work, they release nicotinamide as a byproduct. That nicotinamide must be cleared through a process called methylation, which costs methyl groups. Your body has a finite supply of them, and NMN supplementation meaningfully increases the rate at which they are used. A person who does not replace those methyl groups can end up with elevated homocysteine, a compound that accumulates when the methylation cycle falls behind and that damages blood vessels over time. This is not theoretical: it is the documented mechanism behind why NMN, at higher doses or when combined with creatine, consistently elevates homocysteine in people who are not pairing it with a methyl donor.

NMN is closest in function to NR, which is short for nicotinamide riboside. Both raise NAD+, both are generally safe, and both have human clinical data. NMN's theoretical edge is the possibility that it enters cells via a dedicated transporter rather than first requiring conversion to NR, potentially producing a more direct and larger NAD+ increase. That distinction is still being investigated. What separates NMN from NAM, the cheapest form of vitamin B3, is more practically important: NAM requires an enzyme called NAMPT to be converted to NMN, and NAMPT is subject to feedback inhibition when nicotinamide accumulates. NMN bypasses that bottleneck entirely. At higher doses, NAM can also directly inhibit the sirtuin proteins NMN is trying to fuel. NMN does not carry that risk at typical supplemental doses.

NMN is taken daily. NAD+ has a half-life measured in hours to a few days depending on the tissue, so continuous substrate replenishment is the only way to keep levels elevated. Unlike some compounds where fasted dosing is mechanistically necessary, NMN does not require it. Taking it with a meal, particularly one containing some fat, improves tolerability and supports absorption.

The practical consequence of all this is that an NMN stack is not simply about adding more raw material. It is about keeping the NAD+ conversion pathway properly supplied, keeping the methylation cycle from falling behind the demand NMN creates, and making sure the NAD+ that gets made can reach the downstream proteins that do the biological work.

The Supplements That Matter Most on NMN

There are no dose numbers on this page. The right amount of each of these depends on your actual NMN protocol, your bloodwork, and what else you are already taking. A number written for an average reader is wrong for most specific people. MyPeptidePal works out the amounts from your inputs.

The Rate-Limiting Steps Nobody Warns You About

TMG (Trimethylglycine)

TMG, also called betaine, is the supplement most consistently left off NMN guides, and it is the one with the strongest case for being on this list. Here is the mechanism.

When NAD+ gets used by sirtuins and DNA repair enzymes, it releases nicotinamide as a byproduct. The body clears nicotinamide through methylation, a process that attaches a methyl group to it and tags it for removal. Methyl groups are small chemical units the body needs for dozens of processes simultaneously, including managing homocysteine. NMN supplementation increases how fast the body cycles through its methyl group supply. When creatine is also in the stack, the demand goes higher still: creatine synthesis is one of the single largest consumers of methyl groups in human metabolism.

TMG is a direct methyl donor with three methyl groups per molecule. It donates one through a specific enzyme called BHMT, which converts homocysteine back to methionine. Crucially, this pathway does not require vitamin B12. That means TMG provides a second, independent methylation route that operates alongside the B12-dependent one and catches what it misses. The homocysteine-lowering effect of TMG has been confirmed in randomized controlled trials, which makes this one of the better-evidenced relationships in the longevity supplement space.

The curated data marks TMG as double duty, and the description is accurate. It acts as a cofactor for the methylation the NAD+ pathway demands, and it simultaneously prevents the homocysteine accumulation that high-dose NMN otherwise produces. One supplement covering both roles is meaningful when you are already spending money on the core compound.

Magnesium

Magnesium is a required cofactor for NMNAT, the enzyme family that converts NMN into NAD+. Three versions of this enzyme operate in different compartments of the cell: one in the nucleus, one in the Golgi apparatus and synaptic terminals, and one inside the mitochondria itself. All three require magnesium ions to function. Low intracellular magnesium means slower conversion at all three sites, which means less NAD+ gets made from the NMN you are taking.

Magnesium also drives ATP production in the mitochondria independently of the NAD+ pathway. And because it is required to convert vitamin D into its biologically active form, a magnesium shortfall compounds across multiple systems at once.

The challenge with testing is that standard serum magnesium stays tightly controlled even when the body's stores are depleted. It is not a reliable indicator of intracellular status. The relevant marker is RBC magnesium, which measures what is actually inside red blood cells and reflects the cellular picture rather than the plasma one.

Not all magnesium supplements are equivalent. The glycinate form binds magnesium to the amino acid glycine and is absorbed more efficiently and tolerated more easily by the digestive system than the oxide form, which is cheaper but known for causing loose stools at doses that still fall short of the therapeutic range.

What Actually Synergizes With the NAD+ System

Resveratrol and Pterostilbene

The sirtuins, particularly one called SIRT1, are among the primary downstream proteins that the NAD+ NMN produces goes on to activate. Sirtuins are a family of regulatory proteins involved in cellular stress responses, DNA repair coordination, and mitochondrial regulation. They need NAD+ as a substrate: no NAD+, no sirtuin activity.

Resveratrol and pterostilbene belong to a class of compounds called sirtuin-activating compounds. They directly stimulate SIRT1 rather than supplying it with fuel. The relationship to NMN is complementary rather than redundant: NMN increases the fuel supply, and resveratrol or pterostilbene increase the activation signal. Both inputs are needed for SIRT1 to do its job.

The evidence base deserves honesty. Sirtuin activation by resveratrol is well-established in cell culture and animal models. Human clinical evidence for longevity outcomes is preliminary. Resveratrol also has a well-characterized bioavailability problem: it is rapidly metabolized after oral ingestion and reaches tissues in low amounts unless consumed with a fat-containing meal. Pterostilbene is a structural relative that crosses cell membranes more readily and survives metabolism better, which is why some practitioners prefer it despite the smaller published dataset.

Both are fat-soluble. Taking either one without dietary fat in the same meal substantially limits absorption.

Apigenin and Quercetin

These two work at a different point in the same system. CD38 is an enzyme that degrades NAD+, and it is one of the primary reasons NAD+ levels fall with age. As the body accumulates aging cells and inflammatory signaling increases, CD38 activity rises and it consumes NAD+ at an accelerating rate. Raising NAD+ through NMN while CD38 runs unchecked is a bit like filling a container with a drain partially open.

Apigenin and quercetin are both CD38 inhibitors. They slow NAD+ breakdown rather than adding to its production, which extends the useful life of what NMN makes and raises the steady-state NAD+ level beyond what NMN alone produces. Apigenin is a flavonoid concentrated in parsley and chamomile. Quercetin appears in onions, apples, and other plant foods.

Both show CD38 inhibition in cell culture and animal studies. As of 2026, no human trial has confirmed the effect specifically from supplemental apigenin or quercetin in the context of an NMN stack. This pairing is mechanistically well-supported and widely used in community protocols, but the evidence is experiential and preclinical rather than clinical. That distinction matters and is worth holding onto.

Apigenin carries a dual designation in this stack because the same CD38 inhibition that makes it a synergist during use also makes it a result-preservation tool over a longer horizon, which is why it appears in the next section as well.

CoQ10

CoQ10, known in its active form as ubiquinol, operates as a relay point inside the mitochondria. The mitochondrial energy chain, the sequence of protein complexes that converts food-derived electrons into ATP, feeds on NAD+ at its first major step. CoQ10 accepts electrons from that step and passes them to the next. Without adequate CoQ10, the chain backs up even when NAD+ levels are high. The energy machinery has inputs piling up with no way to move them along.

CoQ10 levels decline with age in a pattern that mirrors NAD+ decline. Some widely prescribed medications, particularly statins that lower cholesterol by blocking a pathway also used in CoQ10 synthesis, meaningfully deplete CoQ10. For anyone running NMN specifically for mitochondrial or energy benefits, a CoQ10 shortfall represents a downstream bottleneck that more NAD+ cannot fix.

Ubiquinol is the reduced, biologically active form. Younger adults convert the more common ubiquinone form into ubiquinol fairly efficiently, but that conversion becomes less reliable with age, which is why the form matters more as a consideration in older adults.

Creatine Monohydrate

Creatine occupies a different energy timescale than NAD+. The mitochondrial machinery that NAD+ fuels produces ATP over sustained periods through a process called oxidative phosphorylation, which is what powers endurance activity and the steady background energy demands of cellular maintenance. Creatine replenishes a fast reserve called phosphocreatine that cells draw on for rapid, short-burst ATP regeneration when energy demand spikes faster than the mitochondria can respond: the first seconds of a sprint, a heavy lift, or any demand that outpaces sustained oxidative metabolism.

The two therefore address complementary timescales of energy production rather than competing for the same role. Pre-clinical data suggests the combination may enhance mitochondrial ATP output, though that specific claim lacks confirmation from human trials.

Creatine also has a well-established record in supporting muscle strength and preservation in aging adults, which overlaps with one of the primary motivations people bring to NMN.

One caveat matters enough to state clearly here. Creatine synthesis is one of the largest consumers of methyl groups in human metabolism. Combining creatine with NMN, which already increases methylation demand through NAD+ catabolism, meaningfully raises the risk of homocysteine accumulation. This is the specific reason TMG becomes more important than optional when these two are stacked together, and the reason the sheet treats TMG as double duty: it is not just a cofactor for NMN alone, it is what keeps the combined stack from driving homocysteine into a range that warrants concern.

Protecting the NAD+ Pool Over Time

Apigenin

Apigenin earns a place in this section for the same mechanism that placed it among the synergists: by inhibiting CD38, it extends the life of the NAD+ pool rather than only supporting its production. The practical difference matters across months of use. NMN raises NAD+ at the input. CD38 degrades it at the output. Running an input-raising compound without addressing the primary degradation pathway leaves a leak in the system.

As noted earlier, the evidence for supplemental apigenin inhibiting CD38 in humans as of 2026 is mechanistic and preclinical rather than clinical. The mechanism is well-characterized in cell and animal research, and the compound appears in food without apparent harm. Community-reported experience from NMN users who include apigenin in their stacks is generally positive, though experience of this kind is not a substitute for trial data. It belongs in the stack on the strength of its mechanism and its low risk profile, not on the strength of a clinical result.

Cautions and Interactions

Anyone with an active cancer diagnosis or a history of cancer should not take NMN without explicit oncologist approval. NAD+ is essential fuel for cellular energy production in all cells, including cancerous ones, and raising NAD+ levels could potentially support tumor cell growth. In the specific case of PARP inhibitor chemotherapy drugs such as olaparib and niraparib, which work by blocking DNA repair enzymes that consume NAD+, NMN directly antagonizes the treatment mechanism by increasing the substrate those enzymes use. This is not a theoretical risk to balance against minor benefits. It is a hard contraindication requiring a specialist conversation before NMN is started.

Pregnancy and breastfeeding: no safety data exists. Avoid.

PARP inhibitors: the direct mechanistic conflict described above applies here regardless of the cancer history question. Do not combine without explicit oncologist involvement.

Diabetes medications: NMN improves insulin sensitivity through SIRT1 and SIRT3 activation. For someone already taking metformin, insulin, or a sulfonylurea, this creates additive glucose-lowering effects and a real hypoglycemia risk. Blood sugar monitoring and prescriber awareness are both appropriate before adding NMN.

Warfarin: NMN has no established interaction with warfarin, and the claims circulating in both directions are worth correcting. Some sources say NAD+ precursors speed warfarin clearance through the liver enzyme CYP2C9 and drop INR; others say they slow it and raise INR. Neither has human evidence behind it. In laboratory work, nicotinamide inhibits some CYP enzymes only at concentrations far above anything supplementation produces in the body, and CYP2C9 in particular shows no meaningful inhibition. No published case report describes NMN or nicotinamide changing anyone's INR. The one real signal in the vitamin B3 family belongs to high-dose extended-release nicotinic acid, a different compound, and it points toward a sharp rise in INR through a mechanism that has nothing to do with liver enzymes. Anticoagulation leaves little room for error, so the prescribing physician should know about NMN before it is started. That is sound practice rather than a documented interaction.

CYP3A4-dependent medications: NMN is sometimes said to inhibit this pathway, affecting drugs including some statins and certain antidepressants. The same caveat applies: the inhibition described in laboratory work occurs at concentrations supplementation does not reach, and no human study has measured an effect on these drugs. Disclose NMN to any prescriber managing medications that depend on this pathway, on general principle rather than on a demonstrated interaction.

High-dose niacin stacked with NMN: niacin generates free nicotinamide that feeds back and inhibits NAMPT, the enzyme in the salvage pathway, and also directly suppresses sirtuin activity at high concentrations. These two compounds work against each other when stacked at high doses.

Multiple NAD+ precursors combined at high doses: stacking NMN with NR, NAM, and additional B3 forms risks excessive nicotinamide accumulation, which turns off the sirtuins rather than activating them. NMN at an appropriate dose is sufficient as a primary NAD+ precursor.

Homocysteine and methyl donors: anyone running NMN without TMG or equivalent methylation support, particularly at higher doses or alongside creatine, should be aware that homocysteine elevation is a real and measurable outcome. It is correctable, and TMG is the primary correction tool, but it requires attention rather than assumption.

Frequently Asked Questions

How much of each supplement should I take with NMN?

There are no dose numbers on this page, and that is intentional. The right amount of TMG, magnesium, resveratrol, creatine, and the rest depends on what dose of NMN you are running, your current bloodwork, whether you are also using creatine, and what medications or health conditions are part of your picture. A number written for an average reader is wrong for most specific people. MyPeptidePal takes your inputs and builds a personalized plan from them.

Which blood markers actually matter when running NMN?

Homocysteine is the most directly relevant marker to watch. NMN increases methylation demand, and a rising homocysteine tells you the cycle is falling behind. RBC magnesium, not standard serum magnesium, which can look normal even when cellular stores are depleted, tells you whether the NMNAT conversion step is adequately supplied. If you are pairing NMN with diabetes medications, fasting blood glucose is worth tracking because NMN improves insulin sensitivity and can shift glucose in a direction that interacts with glucose-lowering prescriptions.

Does NMN work differently from NR, and does that change the stack?

NMN and NR are genuine functional near-twins in most respects: both raise NAD+, both are generally well-tolerated, and both have human clinical data. NMN's theoretical case for superiority rests on the possibility of a dedicated cellular transporter that allows it to bypass the conversion step NR goes through, which may mean a more direct and larger NAD+ increase. The supplement stack for both is nearly identical because the downstream chemistry is the same. The methylation demand NMN creates does not differ meaningfully from what NR creates, and the same synergists activate the same sirtuins regardless of which precursor raised NAD+.

Do I need to take these supplements forever, or just while I am on NMN?

The supplements in this stack support the NAD+ pathway as long as you are running NMN, so their usefulness is tied to continued use. TMG's primary job here is managing the methylation burden NMN creates, which disappears when NMN does. Magnesium and CoQ10 both have independent reasons to maintain regardless of NMN, since each supports mitochondrial function broadly and deficiency in either carries consequences well beyond NMN performance. Whether to continue any of these after stopping NMN is a question about your overall protocol rather than about NMN specifically.

Can I just eat well instead of adding these supplements?

For some of these, diet does real work. Resveratrol and quercetin come from food, and a consistently plant-heavy diet delivers meaningful amounts of both. Magnesium is available in nuts, seeds, and dark leafy greens, and people who eat those regularly may already be reasonably supplied. TMG appears in beets and spinach, but the amounts in food fall well short of what meaningful NMN use demands, particularly when creatine is also in the picture. The honest answer is that diet covers the baseline but rarely closes the gap that NMN creates, especially on the methylation side where the demand is specific and quantifiable.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of NMN and the nutrients that support it in one place.